Malignant tumor
Conditions
Interventions
Vitesoltumab observation group:None
Sponsors
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Applicants must be 18 years old or above, with no gender restrictions. 2.It has been pathologically confirmed as a malignant tumor and is currently receiving treatment with vitesoltumab. 3.At least one course of treatment with vitesoltumab has been completed. 4.Be able to cooperate in completing the assessment of the quality of life scale and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.There is a mental illness or cognitive dysfunction, and one is unable to complete the questionnaire independently. 2.Currently participating in other interventional clinical trials that may affect the assessment of quality of life.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence rate, occurrence time, duration and severity of various adverse reactions during the treatment with vitesoltumab.;The impact of adverse reactions on the overall quality of life of tumor patients was evaluated using; | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of treatment interruption, dose adjustment or treatment termination due to adverse reactions;The incidence of serious adverse events (SAE); | — |
Countries
China
Contacts
Public ContactSuiwen Ye
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Outcome results
None listed